As a consequence of his paper, U.S. President Barack Obama would ask his Bioethics Commission, chaired by Amy Gutmann, to make recommendations about how the emerging technology should be monitored.
The Gutmann heirs claimed that the appearance of a notorious German art dealer, Hans Wendland, in the painting's ownership record should have raised a red flag.